GLP Toxicology & Safety Pharmacology

Comprehensive Safety & Toxicology Solutions

HuaTeng Biotechnology delivers globally accredited preclinical toxicology services to de-risk your drug, chemical, or medical device development. Our AAALAC-accredited facilities support small animal models (rodents, rabbits) and large animal studies (non-human primates, canines, swine) under strict GLP compliance.

Core Services
Acute/Subacute Toxicity Testing (Single & Repeat Dose)
Genotoxicity & Carcinogenicity Studies (Ames Test, Micronucleus)
Reproductive Toxicology (Segment I-III, Developmental & Fertility Assessments)
Safety Pharmacology (Cardiovascular, Respiratory, CNS)
Customized Study Design (Dose-Ranging, ADME/PK Integration)

Why Partner with HuaTeng Biotechnology?

Dual-Capacity Facilities	Global Compliance Expertise	Speed-to-Market Advantage
Dedicated SPF zones for rodents \| AAALAC-certified NHP/dog housing	Full alignment with OECD 423/452, ICH S1-S12, FDA Redbook	Replied within 24 hours to meet your business need
Surgical suites & advanced imaging (PET/CT, MRI)	Audit-ready data packages for EMA/FDA/PMDA submissions	Real-time biometrics dashboards for milestone tracking

Technical Capabilities

Species-Specific Models

Rat

Mouse

Rabbit

Mini-pig

Beagle Dog

Cynomolgus/NHP

Advanced Endpoints

Telemetry-based cardiovascular monitoring

Flow cytometry for immunotoxicity profiling

Digital histopathology (Whole Slide Imaging)

Case Study: Accelerating Oncology IND Approval

FAQ

Q: Do you support combo product testing (drug-device)?
A: Yes. Our team specializes in integrated medical device/drug toxicity assessments per ISO 10993-1 and ICH guidelines.

Q: What's the lead time for acute oral toxicity (OECD 423)?
A: Standard reports delivered in 8-10 weeks, including hematology/biochemistry analysis.

Why Choose HuaTeng Biotechnology for GLP-Compliant Testing?

Trusted Quality. Global Compliance. Proven Execution.

Global Compliance: AAALAC-accredited facilities with IACUC oversight, aligned with EU Directive 2010/63/EU and USDA standards—ensuring full regulatory acceptance across major markets.

Advanced Imaging Capabilities: Integrated platforms including DSA, IVUS, angiography and micro-CT, enabling real-time evaluation of device performance and in vivo outcomes.

Custom Model Development: Species-specific animal models tailored to complex disease conditions, improving translational relevance and clinical predictability.

Integrated Histopathology Suite: SEM and TEM analysis supported by GLP-grade reporting, enabling seamless submission to PMDA, CE Mark and global regulatory authorities.

GLP Toxicology & Safety Pharmacology